What companies are NEU.AX's competitors?

Neuren Pharmaceuticals Limited (NEU.AX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does NEU.AX compare to its peers?

The peer comparison table on this page shows Neuren Pharmaceuticals Limited (NEU.AX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does NEU.AX operate in?

Neuren Pharmaceuticals Limited (NEU.AX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

NEU.AX

Neuren Pharmaceuticals Limited

ASX·Biotechnology · Healthcare

A$22.46A$0.68−2.94%

Market capA$2.85B·Market closed·Aug 21 6:10 AM UTC

Frequently Asked Questions About NEU.AX

What companies are NEU.AX's competitors?: Neuren Pharmaceuticals Limited (NEU.AX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does NEU.AX compare to its peers?: The peer comparison table on this page shows Neuren Pharmaceuticals Limited (NEU.AX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does NEU.AX operate in?: Neuren Pharmaceuticals Limited (NEU.AX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

NEU.AX

Neuren Pharmaceuticals Limited

ASX·Biotechnology · Healthcare

A$22.46A$0.68−2.94%

Market capA$2.85B·Market closed·Aug 21 6:10 AM UTC

Peers


MSB.AX	Mesoblast Limited	A$2.36	A$3.1B
REG.AX	Regis Healthcare Limited	A$6.39	A$1.9B
SNZ.AX	Summerset Group Holdings Limited	A$6.50	A$1.6B
PYC.AX	PYC Therapeutics Limited	A$2.07	A$1.2B
CU6.AX	Clarity Pharmaceuticals Ltd	A$2.48	A$925.2M
CUV.AX	Clinuvel Pharmaceuticals Limited	A$10.42	A$525.3M
ATH.AX	Alterity Therapeutics Limited	A$0.49	A$106.6M
IMM.AX	Immutep Limited	A$0.05	A$78.1M
BOT.AX	Botanix Pharmaceuticals Limited	A$0.02	A$39.8M
EZZ.AX	EZZ Life Science Holdings Limited	A$0.48	A$22.3M

Frequently Asked Questions About NEU.AX

What companies are NEU.AX's competitors?: Neuren Pharmaceuticals Limited (NEU.AX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does NEU.AX compare to its peers?: The peer comparison table on this page shows Neuren Pharmaceuticals Limited (NEU.AX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does NEU.AX operate in?: Neuren Pharmaceuticals Limited (NEU.AX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.